The undisclosed target is a central regulator of inflammation that is distinct from the previously disclosed STAT6 programNurix DEL-AI drug ...
Zacks Investment Research on MSN22h
Nokia Inks Patent License Agreement with Amazon: Stock to Gain?Nokia Corporation NOK recently inked a patent license agreement with Amazon AMZN. Amazon, the e-commerce giant, is also a ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
The designers explained exclusively to WWD the reasons behind their decision to take over production and distribution of the ...
Staff International has filed a lawsuit in the Court of Milan against the label’s twin designers, Dean and Dan Caten, to halt ...
Novo Nordisk has entered into an exclusive license agreement with Lexicon Pharmaceuticals Inc. for LX9851, a first-in-class, ...
Lexicon Pharmaceuticals shares jumped nearly 75% in early trading Friday after the biopharmaceutical company inked a license agreement potentially worth $1 billion with Danish drug maker Novo Nordisk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback